These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33238741)
1. Risk stratification in cardiomyopathy. Sinagra G; Carriere C; Clemenza F; Minà C; Bandera F; Zaffalon D; Gugliandolo P; Merlo M; Guazzi M; Agostoni P Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):52-58. PubMed ID: 33238741 [TBL] [Abstract][Full Text] [Related]
2. Risk stratification in heart failure with mild reduced ejection fraction. Magrì D; Gallo G; Parati G; Cicoira M; Senni M Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):59-64. PubMed ID: 33238737 [TBL] [Abstract][Full Text] [Related]
3. The MECKI score initiative: Development and state of the art. Salvioni E; Bonomi A; Re F; Mapelli M; Mattavelli I; Vitale G; Sarullo FM; Palermo P; Veglia F; Agostoni P Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):5-11. PubMed ID: 33238744 [TBL] [Abstract][Full Text] [Related]
4. Future developments in the MECKI score initiative. Coats AJ Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):72-75. PubMed ID: 33238739 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction. Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342 [TBL] [Abstract][Full Text] [Related]
6. Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Scheel PJ; Florido R; Hsu S; Murray B; Tichnell C; James CA; Agafonova J; Tandri H; Judge DP; Russell SD; Tedford RJ; Calkins H; Gilotra NA J Am Heart Assoc; 2020 Feb; 9(3):e013695. PubMed ID: 32009524 [TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. Finocchiaro G; Haddad F; Knowles JW; Caleshu C; Pavlovic A; Homburger J; Shmargad Y; Sinagra G; Magavern E; Wong M; Perez M; Schnittger I; Myers J; Froelicher V; Ashley EA JACC Heart Fail; 2015 May; 3(5):408-418. PubMed ID: 25863972 [TBL] [Abstract][Full Text] [Related]
8. The Utility of Cardiopulmonary Exercise Testing for the Prediction of Outcomes in Ambulatory Children With Dilated Cardiomyopathy. Chen CK; Manlhiot C; Russell JL; Kantor PF; McCrindle BW; Conway J Transplantation; 2017 Oct; 101(10):2455-2460. PubMed ID: 28145997 [TBL] [Abstract][Full Text] [Related]
9. Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Pugliese NR; De Biase N; Gargani L; Mazzola M; Conte L; Fabiani I; Natali A; Dini FL; Frumento P; Rosada J; Taddei S; Borlaug BA; Masi S Eur J Prev Cardiol; 2021 Dec; 28(15):1650-1661. PubMed ID: 33624088 [TBL] [Abstract][Full Text] [Related]
10. Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction. Corrà U; Magini A; Paolillo S; Frigerio M Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):12-18. PubMed ID: 33238734 [TBL] [Abstract][Full Text] [Related]
12. Comparison of prognostic values of cardiopulmonary and heart rate parameters in exercise testing in men with heart failure. Czubaszewski Ł; Straburzyńska-Lupa A; Migaj J; Straburzyńska-Migaj E Cardiol J; 2018; 25(6):701-708. PubMed ID: 28612902 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope. Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129 [TBL] [Abstract][Full Text] [Related]
14. Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers. Cattadori G; Di Marco S; Farina S; Limongelli G; Monda E; Badagliacca R; Papa S; Tricarico L; Correale M Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):65-71. PubMed ID: 33238743 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis. Zannoni J; Guazzi M; Milani V; Bandera F; Alfonzetti E; Arena R Int J Cardiol; 2023 Jan; 370():402-404. PubMed ID: 36228767 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application. Honold J; DeRosa S; Spyridopoulos I; Fischer-Rasokat U; Seeger FH; Leistner D; Lotz S; Levy WC; Zeiher AM; Assmus B Clin Cardiol; 2013 Mar; 36(3):153-9. PubMed ID: 23377956 [TBL] [Abstract][Full Text] [Related]
17. Development of a cardiopulmonary exercise prognostic score for optimizing risk stratification in heart failure: the (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) study. Guazzi M; Boracchi P; Arena R; Myers J; Vicenzi M; Peberdy MA; Bensimhon D; Chase P; Reina G J Card Fail; 2010 Oct; 16(10):799-805. PubMed ID: 20932461 [TBL] [Abstract][Full Text] [Related]
18. The MECKI score initiative: a successful and ongoing story. Piepoli MF; Corrà U; Agostoni P Eur J Prev Cardiol; 2020 Dec; 27(2_suppl):3-4. PubMed ID: 33238735 [No Abstract] [Full Text] [Related]